rs147923678
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001009944.3(PKD1):c.8948+11C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00193 in 1,609,766 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0029 ( 11 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 48 hom. )
Consequence
PKD1
NM_001009944.3 intron
NM_001009944.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.08
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 16-2102803-G-A is Benign according to our data. Variant chr16-2102803-G-A is described in ClinVar as [Benign]. Clinvar id is 257032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2102803-G-A is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0632 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.8948+11C>T | intron_variant | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00285 AC: 434AN: 152226Hom.: 11 Cov.: 33
GnomAD3 genomes
AF:
AC:
434
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00532 AC: 1315AN: 247146Hom.: 44 AF XY: 0.00486 AC XY: 653AN XY: 134436
GnomAD3 exomes
AF:
AC:
1315
AN:
247146
Hom.:
AF XY:
AC XY:
653
AN XY:
134436
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00184 AC: 2677AN: 1457422Hom.: 48 Cov.: 33 AF XY: 0.00183 AC XY: 1329AN XY: 724928
GnomAD4 exome
AF:
AC:
2677
AN:
1457422
Hom.:
Cov.:
33
AF XY:
AC XY:
1329
AN XY:
724928
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00286 AC: 436AN: 152344Hom.: 11 Cov.: 33 AF XY: 0.00330 AC XY: 246AN XY: 74500
GnomAD4 genome
AF:
AC:
436
AN:
152344
Hom.:
Cov.:
33
AF XY:
AC XY:
246
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
67
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Polycystic kidney disease, adult type Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 31, 2018 | - - |
Polycystic kidney disease Benign:1
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKD1 c.8948+11C>T variant was not identified in the literature nor was it identified in the Clinvitae, ClinVar, MutDB, PKD1-LOVD and PKD1-LOVD 3.0 databases. The variant was identified in dbSNP (ID: rs147923678) as “NA” with a minor allele frequency of 0.0122 (61 of 5000 chromosomes) in the 1000 Genomes Project, NHLBI GO Exome Sequencing Project in 2 of 8574 European American and 1 of 4384 African American alleles, in the Exome Aggregation Consortium database (March 14, 2016) in 598 (18 homozygous) of 119030 chromosomes (freq. 0.005024) in the following populations: East Asian in 519 of 8604 chromosomes (freq. 0.06032), Finnish in 8 of 6588 chromosomes (freq. 0.001214), Latino in 12 of 11528 chromosomes (freq. 0.001041), South Asian in 16 of 16500 chromosomes (freq. 0.0009697), and European (Non-Finnish) in 40 of 65156 chromosomes (freq. 0.0006139), African in 2 of 9768 (freq. 0.0002048) and other in 1 of 886 (freq. 0.001129), increasing the likelihood this could be a low frequency benign variant. The variant was identified in GeneInsight COGR (Benign) and ADPKD Mutation Database (Likely neutral). The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict the abolishment of the consensus splice site; however, HumanSpliceFinder predicts an altered 5' splice site in this region, this information is not very predictive of pathogenicity. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at